Stuart Cain

Ph.D.

Vice President

Business Development, Bowen's FX Therapeutics

Stuart joined Bowen's FX Therapeutics after working in adMare BioInnovations' Program and Business Development team, helping build and grow new biotech companies, one of which was Bowen's FX Therapeutics. Prior to that Stuart spent 10 years in academic research, investigating the mechanisms underling neurological disorders at the University of British Columbia's Michael Smith Labs and Centre for Brain Health. Stuart holds an undergraduate in Pharmacology and a Ph.D in neuropharmacology and neurophysiology. https://www.bowensfx.com/